Telomir Pharmaceuticals Inc (TELO)
6.91
+0.37
(+5.66%)
USD |
NASDAQ |
May 10, 16:00
6.88
-0.03
(-0.43%)
After-Hours: 20:00
Telomir Pharmaceuticals Shareholders Equity (Quarterly): 3.438M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.438M |
| September 30, 2023 | 2.178M |
| Date | Value |
|---|---|
| June 30, 2023 | 3.889M |
| December 31, 2022 | -0.9373M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.9373M
Minimum
Dec 2022
3.889M
Maximum
Jun 2023
2.142M
Average
2.808M
Median
Shareholders Equity (Quarterly) Benchmarks
| Kyverna Therapeutics Inc | -131.40M |
| Metagenomi Inc | 0.00 |
| West Pharmaceutical Services Inc | 2.681B |
| Bio-Path Holdings Inc | 0.441M |
| Chromocell Therapeutics Corp | -5.905M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.774M |
| Total Liabilities (Quarterly) | 1.336M |